Media for Rare Disease Patient Groups Sorsha Roberts Online - PowerPoint PPT Presentation

Dec 05, 2023 •285 likes •558 views

The Importance of Social Media for Rare Disease Patient Groups Sorsha Roberts Online Communications Officer, AKU Society sorsha@akusociety.org 1. Patients on Social Media 2. Reaching Communities 3. Learning to Engage 1. Patients on Social

The Importance of Social Media for Rare Disease Patient Groups Sorsha Roberts Online Communications Officer, AKU Society sorsha@akusociety.org
1. Patients on Social Media 2. Reaching Communities 3. Learning to Engage
1. Patients on Social Media 2. Reaching Communities 3. Learning to Engage
42% 42% found information online
89% of 18-29 year olds
“After a bit of research on the internet, I came across Black Bone Disease, and we requested he be tested.”
ourth
1. Patients on Social Media 2. Reaching Communities 3. Learning to Engage
1000 1000
Patients are on social media
Reduce isolation
Improve education and awareness
Improve standard of care
1. Patients on Social Media 2. Reaching Communities 3. Learning to Engage
patientslikeme.com
rareconnect.org
Patients are using it- so should you!
sorsha@akusociety.org @AKUSociety @SorshaRoberts

Recommend

The Rare Genomics Institute patient research initiative: Probono patient services enabling deep

1 The Rare Genomics Institute patient research initiative: Probono patient services enabling deep insights into rare disease conditions through genome analysis Rajini R Haraksingh, PhD Vice President, Patient Research Rare Genomics Institute

593 views • 20 slides

Partnering with Rare Disease Patient Groups Namrata Taak R&D External Communications, Rare

Partnering with Rare Disease Patient Groups Namrata Taak R&D External Communications, Rare Diseases What we do Pharmaceuticals Vaccines Consumer Healthcare We develop and make We research and make We make a range of consumer

385 views • 17 slides

Rare Disease Clinical Trials Module 2: Exploring Options with your Patient Hea Heath ther er L

Rare Disease Clinical Trials Module 2: Exploring Options with your Patient Hea Heath ther er L Lau, M MD Di Director, , Lysosomal Storage Di Disease Progr gram NY NYU La Langone Health Patients perceptions of a clinical trial

308 views • 17 slides

The Spirit and History of Rare Disease Day Anja Helm, Senior Manager of Relations with Patient

The Spirit and History of Rare Disease Day Anja Helm, Senior Manager of Relations with Patient Organisations, EURORDIS 30/09/2014 eurordis.org eurordis.org 2 The Spirit of Rare Disease Day EURORDIS / Council of National Alliances in 2008

338 views • 22 slides

Patient Inspired Science Establishing a leading, rare and orphan disease-focused biopharmaceutical

Patient Inspired Science Establishing a leading, rare and orphan disease-focused biopharmaceutical company to deliver impactful new medicines to patients H.C. Wainwright & Company 22nd Annual Global Investment Conference September 14, 2020

456 views • 32 slides

CME / CE Rare Disease Clinical Trials Module: Rare Pulmonology Clinical Trials Timothy Craig,

CME / CE Rare Disease Clinical Trials Module: Rare Pulmonology Clinical Trials Timothy Craig, DO Penn State Health Rare Hematologic Conditions Rare Pulmonology Conditions What is a rare disease? A rare disease is any disease affecting

405 views • 14 slides

Pediatric Patient with a Celiac Crisis (Rare Presentation of a Common Disease) Case Report and

Journal of Case Reports and Studies Volume 6 | Issue 3 ISSN: 2348-9820 Case Report Open Access Pediatric Patient with a Celiac Crisis (Rare Presentation of a Common Disease) Case Report and Literature Review Alharbi AO *1 and Alharbi MS 2 1

342 views • 6 slides

From gene discovery to therapies for rare disease a research perspective A/Prof Carol Wicking

From gene discovery to therapies for rare disease a research perspective A/Prof Carol Wicking Director, IMB Centre for Rare Disease Research, UQ Rare Disease Summit 2015 Melbourne 27-28 March Why rare disease? Why now? Why

262 views • 12 slides

RAREDISEASEDAY.ORG 1 Rare Disease Day 2020 13 th edition on Saturday 29 February 2020

RAREDISEASEDAY.ORG 1 Rare Disease Day 2020 13 th edition on Saturday 29 February 2020 A rare day for rare diseases in this leap year! Key campaign message: Rare is many. Rare is strong. Rare is proud! RAREDISEASEDAY.ORG 2

853 views • 15 slides

CME / CE Rare Disease Clinical Trials Focus on Rare Hematologic Clinical Trials Morie A Gertz

CME / CE Rare Disease Clinical Trials Focus on Rare Hematologic Clinical Trials Morie A Gertz MD: Mayo Clinic; Rochester, MN Rare Hematologic Conditions Rare Hematologic Conditions Definition A rare disease is any disease affected less

477 views • 15 slides

2018 S CIENTIFIC W ORKSHOP #10 Conceptualizing an FDA Rare Disease Center of Excellence

@EveryLifeOrg 2018 S CIENTIFIC W ORKSHOP #10 Conceptualizing an FDA Rare Disease Center of Excellence Presented by ANNUAL RARE DISEASE SCIENTIFIC WORKSHOP Improving the Clinical Development Process Thank you to todays sponsors! ANNUAL RARE

618 views • 24 slides

Common Ground: effective partnership for better care in rare disease Dr. Virginia Acha,

Common Ground: effective partnership for better care in rare disease Dr. Virginia Acha, Executive Director, Research , Medical & Innovation In brief Patient-centred care requires greater collaboration on the priorities, methods and

696 views • 23 slides

Challenges with Producing Reliable Evidence for Rare Disease Breakout Advisory Panel on Rare

Challenges with Producing Reliable Evidence for Rare Disease Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars January 27, 2016 Welcome and Agenda Naomi Aronson, PhD Methodology Committee, PCORI Danielle Whicher, PhD, MHS

243 views • 22 slides

and daily life: The Balancing Act of the Rare Disease Community Avril Daly, EURORDIS

Juggling care and daily life: The Balancing Act of the Rare Disease Community Avril Daly, EURORDIS Vice-President 17 th October 2017 Launch event of the Parliamentary Advocates for Rare Diseases #ParliamentAdvocate4Rare Rare diseases A rare

833 views • 26 slides

PSYCHO-SOCIAL EFFECTS OF HAVING A DISEASE LIKE PYRUVATE KINASE DEFICIENCY A PATIENT PERSPECTIVE 6

PSYCHO-SOCIAL EFFECTS OF HAVING A DISEASE LIKE PYRUVATE KINASE DEFICIENCY A PATIENT PERSPECTIVE 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS 1 st Dutch-Belgian meeting for patients and health professionals 21 st - 22 nd November 2015 Amsterdam - The

488 views • 19 slides

Severe, Rare Disease Case Study: Strategy Changes with FDA SPA Sponsors Challenge

Severe, Rare Disease Case Study: Strategy Changes with FDA SPA Sponsors Challenge Raptor Pharmaceu.cals first drug to enter Phase 3 is for a rare metabolic disease severely

181 views • 5 slides

Emil D. Kakkis, M.D., Ph.D. President and Founder* EveryLife Foundation for Rare Diseases

Welcome to Workshop #7: Incorporating the Patient Perspective in Rare Disease Drug Development Emil D. Kakkis, M.D., Ph.D. President and Founder* EveryLife Foundation for Rare Diseases September 15, 2015 * CEO & President, Ultragenyx

681 views • 21 slides

Gene Therapies for Rare Diseases September 13, 2018 Rare Disease Scientific Workshop Everylife

Gene Therapies for Rare Diseases September 13, 2018 Rare Disease Scientific Workshop Everylife Foundation for Rare Diseases Washington, DC Wilson W. Bryan Office of Tissues and Advanced Therapies (OTAT) Center for Biologics Evaluation and

510 views • 20 slides

Rare Disease Issues State by State Newbo Ne born S Screen eening ng Julia J a Jenki kins

Rare Disease Issues State by State Newbo Ne born S Screen eening ng Julia J a Jenki kins Exec ecutive Di e Direc ector, Ever eryLife Foundation f for R Rare Di e Disea eases ses Supporting Rare Disease Patients Through State

573 views • 16 slides

www.R .RareAd areAdvo voca cates.or tes.org DC Office with workstation & meeting space

Designed to be a clearinghouse & advocacy center for all Rare Disease Legislation Provides resources & tools for individuals & organizations All events & resources are free & open to the entire Rare Disease

285 views • 12 slides

C URE T HE P ROCESS 2: Improving the Development Process for Rare Disease Treatments Emil D.

C URE T HE P ROCESS 2: Improving the Development Process for Rare Disease Treatments Emil D. Kakkis, M.D., Ph.D. President and Founder October 29, 2014 1 About the Foundation: Dedicated to Accelerating Biotechnology Innovation for Rare

619 views • 22 slides

Rare Disease Workshop 5: Post Marketing Confirmatory Studies in Rare Diseases Susan Boynton, VP,

Rare Disease Workshop 5: Post Marketing Confirmatory Studies in Rare Diseases Susan Boynton, VP, Global Regulatory Affairs, Shire Mary O'Donovan, Senior Director, Regulatory Affairs & Policy, Biomarin Accelerated Approval: Requirements

318 views • 8 slides

EUROPEAN REFERENCE NETWORKS Matt Bolz-Johnson, EURORDIS Rare Disease Ireland, Dublin, Ireland

EUROPEAN REFERENCE NETWORKS Matt Bolz-Johnson, EURORDIS Rare Disease Ireland, Dublin, Ireland 23 October 2018 Challenges we face as a community Rare diseases and rare cancers can be chronic, progressive, degenerative, disabling and

711 views • 25 slides

Research Prioritization Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars

Research Prioritization Breakout Advisory Panel on Rare Disease Winter 2016 Breakout Webinars January 27, 2016 Welcome and Agenda Marilyn Bull, MD, FAAP Member, Advisory Panel on Rare Disease, PCORI Parag Aggarwal, PhD Senior Program Officer,

354 views • 18 slides